ONCOGENE EXPRESSION IN T-CELL LYMPHOPROLIFERATIVE DISORDERS

被引：6
|
作者：
WOLOSCHAK, GE
HOOPER, WC
DOERGE, MJ
PHYLIKY, RL
WITZIG, TE
BANKS, PM
DEWALD, GW
LI, CY
机构：
[1] MAYO CLIN & MAYO FDN,DEPT IMMUNOL,ROCHESTER,MN 55905
[2] MAYO CLIN & MAYO FDN,DEPT BIOCHEM & MOLEC BIOL,ROCHESTER,MN 55905
[3] MAYO CLIN & MAYO FDN,DEPT PATHOL,ROCHESTER,MN 55905
[4] MAYO CLIN & MAYO FDN,DIV HEMATOL,ROCHESTER,MN 55905
[5] MAYO CLIN & MAYO FDN,CYTOGENET LAB,ROCHESTER,MN 55905
[6] MAYO CLIN & MAYO FDN,DEPT LAB HEMATOL,ROCHESTER,MN 55905
来源：
LEUKEMIA RESEARCH | 1988年 / 12卷 / 04期
关键词：
D O I：
10.1016/0145-2126(88)90048-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：327 / &
相关论文
共 50 条
  • [41] Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: and Outcomes
    Masciopinto, Pierluigi
    Bellitti, Emilio
    Arcuti, Elena
    Battisti, Olga
    Cazzato, Gerardo
    Perrone, Tommasina
    Longo, Maria Chiara
    Laddaga, Filomena Emanuela
    Maiorano, Eugenio
    Musto, Pellegrino
    Ingravallo, Giuseppe
    Gaudio, Francesco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (08): : E745 - E750
  • [42] 2-CHLORODEOXYADENOSINE THERAPY IN PATIENTS WITH T-CELL LYMPHOPROLIFERATIVE DISORDERS
    OBRIEN, S
    KURZROCK, R
    DUVIC, M
    KANTARJIAN, H
    STASS, S
    ROBERTSON, LE
    ESTEY, E
    PIERCE, S
    KEATING, MJ
    BLOOD, 1994, 84 (03) : 733 - 738
  • [43] Genetic Characterization of Indolent T-cell Lymphoproliferative Disorders of the Gastrointestinal Tract
    Patel, Nupam
    Alobeid, Bachir
    Mansukhani, Mahesh M.
    Bhagat, Govind
    MODERN PATHOLOGY, 2017, 30 : 369A - 369A
  • [44] Genetic Characterization of Indolent T-cell Lymphoproliferative Disorders of the Gastrointestinal Tract
    Patel, Bhipam
    Alobeid, Bachir
    Mansukhani, Mahesh M.
    Bhagat, Govind
    LABORATORY INVESTIGATION, 2017, 97 : 369A - 369A
  • [45] THE ARRANGEMENT OF IMMUNOGLOBULIN AND T-CELL RECEPTOR GENES IN HUMAN LYMPHOPROLIFERATIVE DISORDERS
    WALDMANN, TA
    ADVANCES IN IMMUNOLOGY, 1987, 40 : 247 - 321
  • [46] 2-CHLORODEOXYADENOSINE THERAPY IN PATIENTS WITH T-CELL LYMPHOPROLIFERATIVE DISORDERS
    OBRIEN, S
    KURZROCK, R
    DUVIC, M
    STASS, S
    ROBERTSON, LE
    ESTEY, E
    PIERCE, S
    KEATING, M
    BLOOD, 1993, 82 (10) : A141 - A141
  • [47] Interleukin-2-Inducible T-Cell Kinase (ITK) Inhibitors for the Treatment of T-Cell Lymphoproliferative Disorders
    Reneau, John C.
    Hwang, Steven R.
    Murga-Zamalloa, Carlos A.
    Buggy, Joseph J.
    Janc, James W.
    Wilcox, Ryan A.
    BLOOD, 2018, 132
  • [48] Aberrant expression of NK cell receptors in Epstein-Barr virus-positive γδ T-cell lymphoproliferative disorders
    Zhang, Yu
    Ohyashiki, Junko H.
    Shimizu, Norio
    Ohyashiki, Kazuma
    HEMATOLOGY, 2010, 15 (01) : 43 - 47
  • [49] T-CELL RECEPTOR GENE REARRANGEMENT ANALYSIS - CUTANEOUS T-CELL LYMPHOMA, PERIPHERAL T-CELL LYMPHOMA, AND PREMALIGNANT AND BENIGN CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS
    ZELICKSON, BD
    PETERS, MS
    MULLER, SA
    THIBODEAU, SN
    LUST, JA
    QUAM, LM
    PITTELKOW, MR
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 25 (05) : 787 - 796
  • [50] REARRANGEMENT OF T-CELL RECEPTOR DELTA-CHAIN GENE AS A MARKER OF LINEAGE AND CLONALITY IN T-CELL LYMPHOPROLIFERATIVE DISORDERS
    KIMURA, N
    TAKIHARA, Y
    AKIYOSHI, T
    YOSHIDA, T
    OHSHIMA, K
    KAWARA, T
    HISANO, S
    KOZURU, M
    OKUMURA, M
    KIKUCHI, M
    CANCER RESEARCH, 1989, 49 (16) : 4488 - 4492
12345